Sepsis is considered today a major public health problem. Despite that mortality has been consistently associated with organ compromise, the mechanisms by which sepsis causes multiple organ dysfunction are not well understood, and hence, therapy remains reactive and non-specific. Recent studies have challenged previous paradigms by demonstrating that acute kidney injury can occur in the setting of a normal or an even increased renal blood flow, and that it is characterized by tubular injury and not by necrosis or apoptosis. This finding suggests that mechanisms other than hypoperfusion may be at play, and that adaptive responses of the tubular epithelial cell may be key to understanding the origin of organ dysfunction in the setting of sepsis. In this review, we discuss evidence suggesting that the activation of energy regulatory processes and mitochondrial quality control processes may not only be drivers of this response, but also be factors that may alter the course of organ dysfunction during sepsis in clinically relevant ways.

Keywords:
Tubular epithelial cell, Inflammation, AMPK, Mitophagy, Sepsis
1.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2.
Yende S, Iwashyna TJ, Angus DC: Interplay between sepsis and chronic health. Trends Mol Med 2014;20:234-238.
3.
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
4.
Murugan R, Kellum JA: Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011;7:209-217.
5.
Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, et al: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 2013;187:509-517.
6.
Prowle JR, Ishikawa K, May CN, Bellomo R: Renal blood flow during acute renal failure in man. Blood Purif 2009;28:216-225.
7.
Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al: A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014;41:3-11.
8.
Schmidt C, Höcherl K, Schweda F, Bucher M: Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis. Crit Care Med 2007;35:2110-2119.
9.
Mandel LJ, Balaban RS: Stoichiometry and coupling of active transport to oxidative metabolism in epithelial tissues. Am J Physiol 1981;240:F357-F371.
10.
Jin K, Li H, Volpe J, Emlet D, Pastor-Soler N, Pinsky MR, et al: Is acute kidney injury in the early phase of sepsis a sign of metabolic downregulation in tubular epithelial cells? Crit Care 2015;19(suppl 1):P286.
11.
Hsiao HW, Tsai KL, Wang LF, Chen YH, Chiang PC, Chuang SM, et al: The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 2012;37:289-296.
12.
Escobar DA, Botero-Quintero AM, Kautza BC, Luciano J, Loughran P, Darwiche S, et al: Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. J Surg Res 2015;194:262-272.
13.
Hotchkiss RS, Strasser A, McDunn JE, Swanson PE: Cell death. N Engl J Med 2009;361:1570-1583.
14.
Carchman EH, Rao J, Loughran PA, Rosengart MR, Zuckerbraun BS: Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 2011;53:2053-2062.
15.
Howell GM, Gomez H, Collage RD, Loughran P, Zhang X, Escobar DA, et al: Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS One 2013;8:e69520.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.